首页>
外国专利>
MONOCLONAL ANTIBODY REACTIVE AGAINST UNIQUE ANTIGENE BEING GENERALLY PRESENT IN VARIOUS LEUCHAEMIC AND LYMPHOMIC CELLS AND METHOD OF DIAGNOSIS AND TREATMENT FOR THEIR APPLICATION
MONOCLONAL ANTIBODY REACTIVE AGAINST UNIQUE ANTIGENE BEING GENERALLY PRESENT IN VARIOUS LEUCHAEMIC AND LYMPHOMIC CELLS AND METHOD OF DIAGNOSIS AND TREATMENT FOR THEIR APPLICATION
展开▼
机译:普遍存在于各种白血病和淋巴细胞中的抗独特抗原抗原的单克隆抗体及其诊断和治疗方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
A novel hybrid cell line, designated T6-1G9, for production of monoclonal antibodies specific for a unique cell surface antigen, GP20, associated with a wide variety of human lymphomas and leukemias. Hybridoma T6-1G9 was generated by fusing mouse myeloma cells with spleen cells from a BALB/c mouse that was immunized with a human leukemia antigen preparation isolated from the cell membranes of acute lymphoblastic leukemia cells. This invention also provides a method for producing the new monoclonal antibody designated SN7 and to diagnostic procedures using SN7 to detect various leukemias and lymphomas. Also disclosed are methods of using SN7 or reactive fragments of SN7 for the treatment of leukemia-lymphoma patients.
展开▼